A recent PET amyloid and tau accumulation tracers study reported that 52% of patients with diabetes-associated cognitive decline were tau positive, indicating tauopathy-related dementia, while only 29% had an Alzheimer-type pathology [132]. This evidence concerns the gene MAPT and tauopathy.